British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.
Elizabeth J PriceStuart BenjaminMichele BombardieriSimon BowmanSara CartyCoziana CiurtinBridget CramptonAnnabel DawsonBenjamin A FisherIan GilesPeter GlennonMonica GuptaKatie L HackettGenevieve LarkinWan-Fai NgAthimalaipet V RamananSaad RassamSaaeha RauzGuy SmithNurhan SutcliffeAnwar TappuniStephen B WalshPublished in: Rheumatology (Oxford, England) (2024)
Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition-conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.
Keyphrases
- disease activity
- systemic lupus erythematosus
- rheumatoid arthritis
- juvenile idiopathic arthritis
- rheumatoid arthritis patients
- ankylosing spondylitis
- multiple sclerosis
- randomized controlled trial
- oxidative stress
- optical coherence tomography
- systematic review
- escherichia coli
- neoadjuvant chemotherapy
- radiation therapy
- young adults
- cross sectional
- meta analyses